September 4, 2002
Schering Corpration Has Recalled Nasonex Nasal
- The Food and Drug Administration (FDA)
has released the
Nasonex Nasal Spray (mometasone furoate monohydrate) 50 mcg, Net Contents:
17 g, 120 Metered Sprays, FOR INTRANASAL USE ONLY. Rx only. Recall #
1-KTL-147 Exp. date 3.03.
Recalling Firm: Schering Corpration, Kenilworth, NJ, by fax on an unknown
date and by letters on August 12, 2002.
Manufacturer: Schering-Plough Products, Inc., Manati, Puerto Rico. Firm
initiated recall is ongoing.
Defective container; missing part in actuator may cause a narrow stream of
product to be dispensed rather than a fine spray
VOLUME OF PRODUCT IN COMMERCE